Latest News
Yale Cancer Center is pleased to announce that Jennifer Afranie-Sakyi, MD, has been selected by the American Society of Hematology (ASH) to participate as one of nine outstanding fellows in the 2024 ASH Minority Hematology Fellow Award (MHFA). This award encourages early-career researchers from historically underrepresented groups in the United States and Canada to pursue career in academic hematology.
- May 17, 2024Source: The Commonwealth Fund
On The Dose podcast, host Joel Bervell sits down with Dr. Cece Calhoun, a leading adolescent sickle cell specialist from Yale University. T
- May 16, 2024
The findings revealed no statistically significant survival benefit for patients treated at practices that used more systemic therapy compared with those that used less.
- May 16, 2024
The first U.S. trial of varenicline for e-cigarette cessation shows promising results and warrants larger-scale trials, the researchers say.
- May 15, 2024
In an interview, Rachel Perry, PhD, discusses the link between insulin and cancer, a surprising finding in her research, and the future of precision medicine for metabolism-related cancers.
- May 15, 2024
Mary Barden, MD, participates in a Q&A in honor of Brain Tumor Awareness Month.
- May 14, 2024Source: OncLive
“We’re starting to understand more about the biology of SCLC. [Our] work over the years shows that there is heterogeneity, there are different ways to classify SCLC, and, more recently, this idea of transcriptomic or molecular subtypes [has emerged],” Anne Chiang, MD, PhD, associate professor of medicine and associate cancer center director, clinical initiatives, at Yale School of Medicine in New Haven, Connecticut, said in an interview with OncologyLive.
- May 13, 2024
The 48 Yale Cancer Center presentations will include phase II trial results for a cancer vaccine in combination with an immunotherapy drug, a new tool to predict the risk of recurrence of hormone receptor-positive, HER2-negative breast cancer, and the factors affecting sexual function of young women with breast cancer.